CompanyDrug

Roche’s Xofluza Receives FDA Approval for Reducing Influenza Transmission in Phase III Study

CompanyDrug

J&J’s Rybrevant Secures FDA Approval for EGFR/c-MET Non-Small Cell Lung Cancer Treatment

CompanyDrug

Beijing’s Apollobio Receives NMPA Approval for HPV Therapeutic Vaccine VGX-3100

CompanyDrug

Insilico Medicine’s AI-Generated Drug Candidate ISM001-055 Shows Positive Phase II Results in IPF Study

CompanyDrug

Lee’s Pharmaceutical’s Zhaoke Ophthalmology Receives NMPA Approval for Generic Lumigan

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ SHR-1701 Combo Therapy for Gastric Cancer Accepted for Review by China’s NMPA

CompanyDeals

JiCui Cell Therapy Forms Partnership with Fosun Kite to Advance Bispecific CAR-T Cell Therapy Industrialization

CompanyDeals

Apeloa Pharmaceutical Invests in Ji Xing Pharmaceuticals’ Series D Financing Round

Company

CSPC Pharmaceutical Group Appoints Dr. Liu Yongjun as Group CEO and Global R&D President

Company

Sinopharm Holding Appoints New Chairman and President Following Leadership Changes

Medical DevicePolicy / Regulatory

China’s NMPA Releases Standards for Brain-Computer Interface Medical Devices

Company

Sichuan Kelun-Biotech Reports 32.2% Revenue Growth in 2024 H1, Driven by MSD Partnership